Eiji Karashima - Concepedia

Author

Eiji Karashima

University of Maryland, Baltimore ORCID

Also Known As

E Karashima, Eiji KARASHIMA, Eiji Karashima

Publications

267

Citations

H-Index

Concepts

All Affiliations

University of Maryland, Baltimore Shimonoseki City Hospital The University of Osaka Kishiwada Tokushukai Hospital Matsuyama Red Cross Hospital

About

Eiji Karashima is an author at University of Maryland, Baltimore specializing in medicine, vascular biology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	202
2	Health Sciences	1	1	36
3	Public Health	1	1	35
4	Social Sciences	1	1	52
5	Cell Biology	1	1	36

Eiji Karashima

Publications

241

Citations

H-Index

Page 1

	Year	Citations
Ouabain–digoxin antagonism in rat arteries and neurones Hong Song, Eiji Karashima, John M. Hamlyn, The Journal of Physiology Cardiac MuscleMolecular PhysiologyHyperpolarization (Biology)NeurophysiologyMedicine	2013	52
1-Year Outcomes of Thromboendarterectomy vs Endovascular Therapy for Common Femoral Artery Lesions Tatsuya Nakama, Mitsuyoshi Takahara, Yo Iwata, JACC: Cardiovascular Interventions Thrombosis1-Year OutcomesEndovascular TechniqueCardiovascular DiseasePeripheral Intervention	2022	37
Increased arterial smooth muscle Ca<sup>2+</sup> signaling, vasoconstriction, and myogenic reactivity in Milan hypertensive rats Cristina I. Linde, Eiji Karashima, Hema Raina, American Journal of Physiology-Heart and Circulatory Physiology HypertensionMyogenic ReactivityRenal InflammationCardiovascular FunctionMolecular Pharmacology	2011	36
Low-dose ouabain constricts small arteries from ouabain-hypertensive rats: implications for sustained elevation of vascular resistance Jin Zhang, John M. Hamlyn, Eiji Karashima, American Journal of Physiology-Heart and Circulatory Physiology HypertensionCardiovascular PharmacologyCardiovascular FunctionBlood PressureProlonged Ouabain Administration	2009	35
Cross Talk Between Plasma Membrane Na+/Ca2+ Exchanger-1 and TRPC/Orai-Containing Channels: Key Players in Arterial Hypertension Maria V. Pulina, Alessandra Zulian, Sergey G. Baryshnikov, Advances in experimental medicine and biology HypertensionMolecular PhysiologySignal TransductionMedicinePhysiology	2012	27
Usefulness of the “Non-Slip Element” Percutaneous Transluminal Angioplasty Balloon in the Treatment of Femoropopliteal Arterial Lesions Eiji Karashima, Shunsuke Yoda, Shioto Yasuda, Journal of Endovascular Therapy	2019	18
Emphysematous Cystitis with Venous Bubbles Eiji Karashima, Junichi EJIMA, Hirofumi Nakamura, Internal Medicine Right AtriumUrologyVenous DiseaseNeurogenic BladderVenous Bubbles	2005	15
One-Year Clinical Outcomes following Implantation of Innova<sup>TM</sup> Self-Expanding Nitinol Stents in Patients with Peripheral Artery Diseases Presenting Femoropopliteal Artery Lesions Takuya Tsujimura, Mitsuyoshi Takahara, Osamu Iida, Journal of Atherosclerosis and Thrombosis	2019	11
Application of first-generation high- and low-dose drug-coated balloons to the femoropopliteal artery disease: a sub-analysis of the POPCORN registry Masahiko Fujihara, Mitsuyoshi Takahara, Yoshimitsu Soga, CVIR Endovascular	2023	10

Page 1